The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs." The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.
Recent comments
5 days 14 hours ago
6 days 1 hour ago
2 weeks 1 day ago
7 weeks 2 days ago
9 weeks 5 days ago
14 weeks 6 days ago
26 weeks 5 days ago
28 weeks 6 days ago
29 weeks 6 days ago
38 weeks 3 days ago